Sterling Capital Management »

Black Diamond Therapeutics shares owned by Sterling Capital Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Sterling Capital Management from 13F filings

Historical chart of Sterling Capital Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Sterling Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $278 64 4.34